摘要
目的:研究自体输血在恶性肿瘤患者中应用的可行性和积极意义。方法:对比应用自体输血和异体输血的疗效、预后。结果:肿瘤患者采用自体输血的反应率低于异体输血,5年存活率明显提高(P<0.01)。结论:自体输血在恶性肿瘤患者手术中的应用是可行的、安全的,能够延长患者的生命。
Objective :To explore the feasibility of autoreinfusion in the operation of malignant tumor. Methods :To compare the curative effect and prognosis in autoreinfusion and xenogenous transfusion. Results :The response rate in autoreinfusion was lower than which in xenogenous transfusion, the livability of five years increased obviously(P〈0.01). Conclusion :Autoreinfusion in the operation of malignant tumor is feasible, safe and can prolong the livability of the sufferer.
出处
《中国医药导报》
CAS
2008年第30期46-47,共2页
China Medical Herald
关键词
自体输血
恶性肿瘤
免疫抑制
Autoreinfusion
Malignant tumor
Immunological suppression